Technology
StemTroniX, Inc. Technology
StemTroniX, Inc. is the premier source of technology for the transfusion of adult stem cells. The adult stem cells are autologous representing the same type of therapy as the bone marrow transfusion used in cancer and other hematopoietic conditions, including pernicious anemia, etc.
StemTroniX, Inc. proprietary technology includes:
1. ImStC STX : Image Adult Stem Cells at site of engraftment with IP protected proprietary agents.
2. Use of non invasive technologies for Adult Stem Cell transfusion into damaged area of a specific organ.
3. Patent disclosure application method using no poisonous dyes to follow the stem cells during their voyage to the damaged part of the specific organ.
4. Imaging stem cells at the point of specific damage.
5. Determine short term and long term success of engraftment and repair of Tissue damaged organs.
- EgTMP STX : Viable stem cells using metabolic pathways producing greater engraftment with proprietary products.
- DlStC STX : Patented delivery system for adult stem cells and other products.
- Combination of Imaging, delivery system and protection of adult stem cells in transfusions for engraftment of damaged organs.
For more information, potential for collaborations, potential for licensing, contact us at info@stemtronix.com